Annual report pursuant to Section 13 and 15(d)

Statements of Preferred Stock and Stockholders' Equity (Deficit)

v3.3.1.900
Statements of Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
Total
Series A Convertible Preferred Stock [Member]
Series A Non-Convertible Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2013 $ (1,783,198) $ 1,106,609 $ 2,000 $ 696 $ 102,696 $ (1,886,590)
Beginning balance, shares at Dec. 31, 2013   1,835,212 200,000 6,964,788    
Issuance of Series A preferred stock/ common stock at inception of Corbus       $ 600 (600)  
Issuance of Series A preferred stock/ common stock at inception of Corbus, shares       6,000,000    
Conversion of Series A convertible preferred stock into common stock upon reverse acquisition 1,108,609 $ (1,106,609) $ (2,000) $ 204 1,108,405  
Conversion of Series A convertible preferred stock into common stock upon reverse acquisition, Shares   (1,835,212) (200,000) 2,035,212    
Issuance of common stock in private placement, net of issuance costs of $1,857,668 8,402,332     $ 1,026 8,401,306  
Issuance of common stock in private placement, shares       10,260,000    
Issuance of common stock in exchange for settlement of debt 396,192     $ 54 396,138  
Issuance of common stock in exchange for settlement of debt, shares       541,948    
Stock compensation expense 193,120       193,120  
Issuance of common stock upon exercise of warrants 33,333     $ 5 33,328  
Issuance of common stock upon exercise of warrants, shares       48,693    
Issuance of common stock upon exercise of stock options $ 4,450     $ 9 4,441  
Issuance of common stock upon exercise of stock options, shares 87,691     87,691    
Reclassification of derivative warrant liability $ 48,380       48,380  
Ending balance, shares at Dec. 31, 2014       25,938,332    
Net Loss (2,540,485)         (2,540,485)
Ending balance at Dec. 31, 2014 5,862,733     $ 2,594 10,287,214 (4,427,075)
Stock compensation expense 1,153,302       1,153,302  
Issuance of common stock upon exercise of warrants 10,814,125     $ 1,162 10,812,963  
Issuance of common stock upon exercise of warrants, shares       11,615,674    
Issuance of common stock upon exercise of stock options $ 5,589     $ 5 5,584  
Issuance of common stock upon exercise of stock options, shares 51,128     51,128    
Ending balance, shares at Dec. 31, 2015       37,605,134    
Net Loss $ (8,850,739)         (8,850,739)
Ending balance at Dec. 31, 2015 $ 8,985,010     $ 3,761 $ 22,259,063 $ (13,277,814)